Science is hard. Commercializing it can be easy with Merito.
Why Work with Merito?
Advantage 1: Quick Fundraising
Researchers can be matched with investors quickly after Merito onboards their project. No complex grant writing is needed. Depending on the project, Merito can either seek funds via corporate R&D teams or via the$2 billion and growing in capital from the decentralized science (DeSci) financial system.
Advantage 2: No Restrictions on Themes or Funds Use
Compared to traditional grants, researchers have more freedom in how they use funds. Salaries can be paid using funds from Merito deals, for example.
Advantage 3: Science Community
Through connections with IP token investors, scientists gain access to a community of PhD peers and researchers from their field of study. This expanded community helps labs recruit human resources too.
Advantage 4: Gaining Champions to Find Corporate License Buyers
For DeSci deals, those contributing are motivated to find pharma and other companies to in-license IP from research projects like yours.
Access global investors ready to fund your deeptech innovations.
Maintain full control of your intellectual property and equity.
Secure funding through structured Sponsored Research Agreements (SRAs).
Success Stories
Thanks to Merito’s introduction, a U.S.-based investor was able to jointly produce a novel therapeutic with a Japanese biotech business.
Merito connected a Kyushu-based laboratory to undertake a blood-based biomarker of aging project for a Tokyo-based biotech company.
The Fukuoka (Japan) Governor’s Office hired Merito to make introductions to 11 U.S. biotech investors for five Fukuoka biotech ventures.
Merito connects Asia-based deep tech innovators to global capital
English